Pathology is the clinical discipline that gives symptomatic data to patients and clinicians. It influences virtually all parts of patient consideration, from diagnosing malignant growth to overseeing constant illnesses through precise research facility testing. With the presence of professional researchers, scientists involved in the development of high-quality education & research in all aspects, we are organizing 21st European Pathology Congress at Paris, France during September 11-12, 2023.

According to Fortune Business Insights, the global digital pathology market size is expected to reach USD 2,045.9 million in 2029 from USD 892.5 million in 2022 and estimated to grow at a CAGR of 12.6% during forecast period (2022-2029). Rising awareness of novel diagnostics and the increasing prevalence of chronic disorders are likely to incite market growth.

The digital pathology and telepathology market have been analyzed for the four main geographic regions: North America, Europe, Asia-Pacific, and the Rest of the World (RoW). The growth of the market is majorly driven by the high incidence of cancer and other target diseases, recommendations for cancer screening, availability of reimbursement, and the growth focus on personalized medicine. In addition, emerging economies such as China, India and Brazil are expected to offer significant growth opportunities for players operating in market. However, the availability of refurbished products, the lack of skilled professionals, and product recalls are expected to hamper the market growth to as certain extent in coming years.